Emerging Tech

Searching For Innovations? The Technological Determinants Of Acquisitions In The Pharmaceutical Industry

Download Now Free registration required

Executive Summary

This paper analyzes the individual determinants of acquisition activity and target choices in the pharmaceutical industry over the period 1978-2002. The "Innovation gap" hypothesis states that acquiring firms lack promising drug compounds and acquire firms with more promising drug prospects. A duration model implemented over a panel of more than 400 firms relates the probabilities of being a purchaser or a target to financial, R&D and patent data to investigate this explanation more deeply. Results show that purchasers are firms with a lower Tobin's Q and decreasing sales, which could indicate that acquisitions are used to compensate for low internal growth prospects.

  • Format: PDF
  • Size: 470.2 KB